StockData
Lisata Therapeutics, Inc. logo

Lisata Therapeutics, Inc. (LSTA) stock

LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.04−0.05 (-4.59%)

Close on Nov 17, 2026Market cap $9.37MP/E –Yield –

Lisata Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Lisata Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $100.00K, down 90.7% year over year. For fiscal 2025 it was $170.00K, down 83.0% from the year before. Over ten years it grew -45.2% a year on average. The highest annual figure on record is $69.82M in fiscal 2010.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$170.00K-83.0%
FY2024Dec 31, 2024$1.00M–
FY2023Dec 31, 2023$0–
FY2022Dec 31, 2022$0-100.0%
FY2016Dec 31, 2016$35.28M+56.9%
FY2015Dec 31, 2015$22.49M+25.4%
FY2014Dec 31, 2014$17.94M+22.3%
FY2013Dec 31, 2013$14.67M+2.4%
FY2012Dec 31, 2012$14.33M+42.6%
FY2011Dec 31, 2011$10.05M-85.6%
FY2010Dec 31, 2010$69.82M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0-100.0%
Q1 FY2026Mar 31, 2026$0–
Q4 FY2025Dec 31, 2025$100.00K-90.0%
Q3 FY2025Sep 30, 2025$0–
Q2 FY2025Jun 30, 2025$70.00K–
Q1 FY2025Mar 31, 2025$0–
Q4 FY2024Dec 31, 2024$1.00M–
Q3 FY2024Sep 30, 2024$0–
Q2 FY2024Jun 30, 2024$0–
Q1 FY2024Mar 31, 2024$0–
Q4 FY2023Dec 31, 2023$0–
Q3 FY2023Sep 30, 2023$0–
Q2 FY2023Jun 30, 2023$0-100.0%
Q1 FY2023Mar 31, 2023$0-100.0%
Q4 FY2022Dec 31, 2022$0-100.0%
Q3 FY2022Sep 30, 2022$0–
Q1 FY2017Mar 31, 2017$7.92M–
Q4 FY2016Dec 31, 2016$10.18M–
Q3 FY2016Sep 30, 2016$9.32M–

More Lisata Therapeutics figures

See a number that looks wrong?